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Abstract: Drug addiction is a chronic brain disease characterized by a persistent risk of relapse, even after a long period 
of abstinence. A current hypothesis states that relapse results from lasting neuroadaptations that are induced in response to 
repeated drug administration. The adaptations require gene expression, some of which being under the control of stable 
epigenetic regulations. We have previously demonstrated that pretreatment with histone deacetylase (HDAC) inhibitors 
reduces the cocaine reinforcing properties as well as the motivation of rats for cocaine. We show here that the same 
HDAC inhibitors, trichostatin A and phenylbutyrate, significantly reduced the cocaine-seeking behavior induced by   
the combination of a cocaine injection together with the exposure to a light cue previously associated with cocaine taking. 
Reinstatement of drug-seeking behavior was carried out after a 3-week withdrawal period, which came after ten daily  
sessions of cocaine intravenous self-administration. Our results suggest that pharmacological treatment aimed at modulating 
epigenetic regulation, and particularly treatment that would inhibit HDAC activity, could reduce the risk of relapse, a  
major drawback in the treatment of drug addiction.  
Keywords: Drug dependence, cocaine self-administration, cocaine-seeking behavior, epigenetic regulation, histone deacety-
lase, trichostatin A, phenylbutyrate. 
INTRODUCTION 
  Drug dependence is currently viewed as a chronic brain 
disease characterized primarily by a compulsive drug-
seeking and drug-taking behavior. The development of de-
pendence to drugs of abuse occurs over time and requires 
cellular adaptations. Characterization of long-term plasticity 
underlying addiction is currently an intensive research area 
and concerns mainly the characterization of changes in gene 
expression evoked by drugs of abuse [1]. Several studies 
have highlighted the importance of epigenetic regulations of 
gene transcription in diverse aspects of psychiatric disorders, 
including addiction [2-4]. Epigenetic regulations are com-
plex mechanisms that control neuronal gene transcription by 
regulating the accessibility of genes to the transcriptional 
machinery [5]. Access to DNA in the nucleosome is 
achieved via complex associations of proteins in which post-
translational modifications of histones play a major role. In 
general, increased histone acetylation is associated with 
DNA relaxation and elevated transcriptional activity, 
whereas decreased acetylation brought about by histone 
deacetylases (HDACs) results in tighter DNA coiling and 
gene silencing [6-8].  
  We have shown that repeated injections of cocaine regu-
late chromatin remodeling by inducing the methyl-CpG-
binding proteins MeCP2 and MBD1 in rat brain [2]. The 
manipulation of chromatin remodeling enzymes by pharma-
cological inhibition revealed that cocaine-induced changes in  
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chromatin structure are behaviorally relevant. We showed 
for instance that treatment with the HDAC inhibitors 
trichostatin A (TsA) or phenylbutyrate (PhB) reduces the 
cocaine reinforcing properties under a fixed-ratio 1 (FR1) 
schedule of cocaine intravenous (i.v.) self-administration 
protocol [9]. Experiments using the progressive-ratio sched-
ule of reinforcement showed that HDAC inhibition also at-
tenuated the motivation of rats for cocaine, but not for the 
natural reinforcer sucrose.  
  A unique characteristic of addiction, from a clinical point 
of view, is the persistence of relapse risk long after a person 
has stopped taking drugs, which constitutes a major obstacle 
to successful treatment [10]. Much drug taking, including 
late relapses, follows exposure to cues previously associated 
with drug use [11, 12]. The cues include external sensory 
stimuli such as drug paraphernalia as well as interoceptive 
stimuli [13]. In animal models, reinstatement of drug self-
administration is strongly motivated by re-exposure to even 
small doses of the drug, and therefore to positive reminders 
of drug use. Given that HDAC inhibitors were able to reduce 
the cocaine reinforcing properties in rats under an i.v. self-
administration protocol, we investigated in the present study 
whether the HDAC inhibitors would also modulate the co-
caine-seeking behavior reinstated by the combination of co-
caine-priming and cocaine-related cues after a withdrawal 
period. 
MATERIALS & METHODS 
Animals and Treatment 
  Male Wistar rats (Janvier, France), weighing 150–175 g, 
were housed in standard home cages under an inverted 12 h 22    Current Neuropharmacology, 2011, Vol. 9, No. 1  Romieu et al. 
light/dark cycle (lights on at 7:00 PM). Animals had access 
to food and water ad libitum. After surgery for i.v. catheter 
implantation, they were housed in individual cages. They 
were allowed to recover for 5–7 days before the beginning of 
the self-administration sessions which were conducted dur-
ing the dark period. All procedures involving animal care 
were conducted in compliance with current laws and policies 
(Council directive 87848, Service Vétérinaire de la Santé et 
de la Protection Animales; permission 67-165 to JZ). Co-
caine hydrochloride (Cooper, France) solution was adjusted 
with 0.9% NaCl to infuse an i.v. dose of 0.33 mg/kg/ 
injection during self-administration session. TsA (Sigma-
Aldrich), sodium 4-phenylbutyrate (Fluka, Sigma-Aldrich) 
or 10% DMSO in saline were administered i.v. Catheteriza-
tion procedure into the jugular vein was performed as previ-
ously described [9].  
Cocaine Operant Self-Administration and Reinstatement 
Procedure 
  Studies were conducted in dark operant chambers (30  
30  30 cm) located in a sound-attenuated room [9]. Each 
chamber was equipped with two 3 cm-diameter holes on the 
same wall, located 4 cm above the floor; one was selected as 
the active hole for delivering the reinforcer and the other as 
the inactive hole. They were counterbalanced between right 
and left position in the various groups of rats. Nose-pokes 
(NPs) into the inactive hole had no programmed conse-
quence. When the number of required NPs into the active 
hole was reached, a 40 l cocaine solution was delivered 
during a 3-sec period. A stimulus green light (3Hz flash), 
located 8 cm above the active hole, was paired contingently 
with the delivery of cocaine (3 sec). Immediately after each 
cocaine infusion, a white house light was switched on and 
persisted during a 40-sec time-out period. 
  For cocaine self-administration procedure [14], rats were 
submitted to an FR1 schedule of reinforcement during daily 
1 h sessions for 10 days. In this schedule, each NP into the 
active hole during the valid period triggered an i.v. infusion 
of cocaine solution. No cutoff was applied concerning the 
number of self-infusions the rat was able to perform during 
the session. After the 10-day period of self-administration, 
rats were submitted to a withdrawal period of 3 weeks, dur-
ing which they were housed individually in their home 
cages. Starting 4 days before the reinstatement session, they 
were i.v. injected daily with the HDAC inhibitors or with 
vehicle (10% DMSO in saline), the fifth and last injection 
occurring the day of the reinstatement, 30 min before the 
session. The reinstatement session started immediately after 
rats were given i.p. injections of 15 mg/kg cocaine. NPs per-
formed in each hole were then recorded for 1 h. NPs in the 
active hole successively turned on the green light for 3 sec 
and the house light for 40 sec, but no cocaine solution was 
delivered during the reinstatement session. 
RESULTS 
  When rats were trained to i.v. self-administer cocaine 
(0.33 mg/kg/injection) during daily 1-h sessions under a FR1 
schedule of reinforcement, a stable behavior could be   
observed after 3 sessions (data not shown), that remained 
until the tenth session. At the end of the self-administration 
period, four balanced groups of rats were established from 
the results obtained during the 3 last sessions, so that they 
displayed a similar pattern of behavior in terms of number of 
injections, as shown in Fig. (1A) as well as of NP activity in 
the active and inactive holes, as depicted in Fig. (1B). The 
percentage of NPs performed in the active hole by all groups 
was higher than 80% during the three last sessions (data not 
shown). Rats were then submitted to a 3-week period of 
withdrawal. 
  Animals were treated daily with the HDAC inhibitors or 
vehicle for five consecutive days, the last injection occurring 
30 min before the reinstatement session. Fig. (2) shows that 
during the 1-h session, i.v. injection of 0.3 mg/kg TsA sig-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). I.v. cocaine self-administration by rats during the 3 last 
FR1 sessions. Rats were trained to self-administer cocaine (0.33 
mg/kg/injection) during daily 1-h sessions under a FR1 schedule of 
reinforcement for 10 days. Results for the 3 last sessions are pre-
sented as (A), the number of self-injections performed during each 
session; (B), the number of NPs achieved in the active and inactive 
holes. Results are expressed as means ± sem. Rats were dispatched 
into several groups, as indicated, in view of the pharmacological 
treatment beginning 4 days before the reinstatement session. Control 
vehicle-treated group, n =11; 0.3 mg/kg TsA, n = 12; 20 mg/kg PhB, 
n = 7; 100 mg/kg PhB, n = 8. The Inhibition of Histone Deacetylases Reduces the Reinstatement  Current Neuropharmacology, 2011, Vol. 9, No. 1    23 
nificantly reduced the cocaine- and cue-induced reinstate-
ment of cocaine-seeking behavior. When compared to con-
trol vehicle-treated animals, rats treated with TsA reduced 
the number of NPs directed towards the active hole by a 
mere 57%. Similarly, treatment with the HDAC inhibitor 
PhB produced a marked dose-dependent reduction in co-
caine-seeking behavior in rats, since the number of NPs 
achieved into the active hole was reduced by 36% and 59%, 
when animals were treated i.v. with 20 and 100 mg/kg PhB, 
respectively. It is noteworthy that the NPs achieved into the 
inactive hole, representing about 18% of those realized into 
the active hole for the control group of rats, were similar in 
all the groups considered (Fig. 2).  
 Fig.  (3) illustrates the cocaine-seeking behavior of the 
same groups of rats, but considering shorter time-intervals 
than the whole 1 h reinstatement session. It is shown that 
control rats realized most of their NPs during the first 30-min 
period, with a maximum occurring during the 20 to 30 min 
interval, and then the number of NPs progressively decreased 
towards the end of the session. No statistical difference could 
be established between the different intervals, though. In 
contrast, animals treated with TsA completed less NPs dur-
ing the first 10-min interval, and the number of NPs re-
mained quite stable during the entire session, achieving sta-
tistically significant differences when compared to control 
rats. The low dose of PhB produced a somehow linear de-
cline in the number of NPs rats were achieving during the 
reinstatement session, with statistically significant differ-
ences being noticed for the second and third interval. The 
higher PhB dosage produced a profile similar to that ob-
served in TsA-treated animals, with statistically significant 
differences, compared to control rats, being found for three 
out of the six 10-min time intervals considered. 
DISCUSSION 
  Since we have previously reported that pretreatment with 
HDAC inhibitors reduces the cocaine reinforcing properties 
as well as the motivation of rats for cocaine [9], we investi-
gated in the present study whether these pharmacological 
agents were also able to affect the cocaine-seeking behavior. 
To this end, we trained rats under an FR1 schedule of i.v. 
cocaine self-administration protocol for ten days, which was 
followed by a 3-week withdrawal period. The reinstatement 
 
 
 
 
 
 
 
 
 
Fig. (2). Effect of TsA and PhB on the combination of cocaine- 
and cue-induced reinstatement of cocaine-seeking behavior. 
Rats were i.v. injected daily with vehicle or with the indicated 
HDAC inhibitor, beginning 4 days before the reinstatement session. 
They were treated again 30 min before being injected i.p. with 15 
mg/kg cocaine and placed immediately in the self-administration 
chamber. Numbers of NPs, expressed as means ± sem, realized in 
the active and inactive holes during the 1-h test session are shown. 
*p < 0.05, comparison between pharmacological and vehicle treat-
ment (One-way Kruskal-Wallis ANOVA followed by Dunn’s post 
hoc test). 
 
 
 
 
 
 
 
 
 
Fig. (3). Time-course of the effect of TsA and PhB on the combination of cocaine- and cue-induced reinstatement of cocaine-seeking 
behavior. Rats were treated as indicated in the legends to Figs. (1) and (2). Numbers of NPs, expressed as means ± sem, realized in the  
active and inactive holes during 10-min intervals in the reinstatement session are shown. *p < 0.05, comparison between pharmacological 
and vehicle treatment (Two-way ANOVA, treatment X time for repeated measures, followed by the Holm-Sidak post hoc test). 24    Current Neuropharmacology, 2011, Vol. 9, No. 1  Romieu et al. 
session was carried out after a treatment for 5 days with the 
HDAC inhibitors. A 5-day treatment was selected because  
we noticed previously that TsA, at the dosage of 0.3 mg/kg, 
produced a statistically significant effect on cocaine self-
injections from the third session [9]. We show here that both 
TsA and PhB significantly reduced the cocaine-seeking be-
havior induced by the combination of a cocaine injection 
together with the exposure to a light cue previously associ-
ated with cocaine taking. While this does not allow to iden-
tify which one of the two parameters is primarily affected by 
the HDAC inhibitors, we consider that the combination of 
both stimuli is more appropriate to model the situation that 
addicted individuals are facing. While TsA had a strong ef-
fect at the dose of 0.3 mg/kg, it took up to 100 mg/kg of PhB 
to reduce significantly the cocaine-seeking behavior. This is 
actually in agreement with their respective inhibition po-
tency: TsA, a member of the hydroxamate group of HDAC 
inhibitors, displays an in vitro IC50 in the nanomolar range 
[15], whereas PhB, from the class of aliphatic acids, has an 
affinity in the micromolar range [16]. The two inhibitors 
show no selectivity for particular members of class I, II or IV 
HDACs [16]. 
  The data show that five daily sessions of TsA or PhB 
injection remodeled chromatin sufficiently to become behav-
iorally relevant, by preventing the reinstatement of drug-
induced behavioral changes. This is in agreement with our 
previous data showing that the HDAC inhibitors reduced the 
reinforcing properties of cocaine [9]. The results are also in 
line with a recent report showing that administration of an 
HDAC inhibitor facilitates the extinction of cocaine-induced 
conditioned place preference and reduces the reactivation of 
place preference [17]. The similar results obtained when 
using the two paradigms (drug self-administration and condi-
tioned place preference) clearly indicate that neuroadapta-
tions taking place in response to repeated cocaine injections 
and underlying drug craving [18] are under the control of 
epigenetic regulations of gene expression, which involve 
modification of histone acetylation. It is noteworthy that 
intrahippocampal delivery of HDAC inhibitors has been 
shown to facilitate fear extinction in a contextual fear condi-
tioning paradigm [19]. On the opposite, TsA administration 
to mice after a spatial learning task phase was found to im-
prove the memory performances during the retention phase 
[20]. Together, the data suggest that other cognitive proc-
esses than only memory/learning mechanisms underlie drug 
extinction and drug seeking behavior, in line with the fact 
that drug addiction concerns other brain structures, such as 
the nucleus accumbens or the dorsal striatum, than those 
involved in spatial memory. 
  Since chromatin remodeling was sufficient to alter a be-
havior as elaborate as drug-seeking, an animal model of drug 
relapse, the findings provide a potential novel target for the 
development of treatments that would facilitate reduction in 
drug dependence. It should be noted that HDAC inhibitors 
were efficient in reducing cocaine-seeking behavior despite 
the severe conditions the test was carried out. In effect, one 
has to consider that i) we used a combination of cocaine   
injection and exposure to a light cue to induce cocaine   
reinstatement; ii) rats were not submitted to an extinction 
protocol after the self-administration training procedure, but 
to a withdrawal period. In the latter condition, being back to 
the context of the test chamber was probably accountable for 
some NP activity (in addition to drug priming) developed by 
the rats during the reactivation session.  
  In conclusion, our results strongly suggest that treatment 
aimed at modulating epigenetic regulations, especially the 
pharmacological inhibition of HDAC activity, could reduce 
the risk of relapse, a major drawback in the treatment of drug 
addiction.  
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